Skip to main content

Ironworkers Local Union 68 v. Astrazeneca Pharmaceuticals, LP

11th CircuitMarch 11, 2011No. 08-16851Cited 118 times
Facing something similar at work?Check your rights — free, private, no sign-up

Case Details

Judge(s)
Tjoflat, Pryor, Martin
Status — whether other courts must follow this ruling
Published
Procedural Posture — the stage the case had reached
appeal

Related Laws

No specific laws identified for this ruling.

Outcome

The Eleventh Circuit affirmed the district court's dismissal of all claims against AstraZeneca, holding that the plaintiffs failed to adequately plead economic injury as required under RICO and state consumer protection laws because they did not allege the prescribed Seroquel was medically unnecessary or inappropriate.

What This Ruling Means

**The Dispute** Ironworkers Local Union 68, a labor union, sued pharmaceutical company AstraZeneca, claiming the company committed fraud and violated federal racketeering laws (RICO). The union alleged that AstraZeneca deceived doctors and patients about its antipsychotic drug Seroquel, causing the union's health insurance plan to pay for expensive prescriptions that weren't needed. **The Court's Decision** The Eleventh Circuit Court of Appeals ruled in favor of AstraZeneca and dismissed all claims against the company. The court found that the union failed to prove they suffered actual economic harm. Specifically, the union couldn't show that the Seroquel prescriptions were medically unnecessary or inappropriate for patients. Without proving the medications were unneeded, the union couldn't demonstrate they lost money due to AstraZeneca's alleged misconduct. **What This Means for Workers** This ruling shows how difficult it can be for unions and employee benefit plans to sue pharmaceutical companies over drug marketing practices. Even if workers believe a company misled doctors about a medication, they must prove the prescribed drugs were actually unnecessary to win damages for wasted insurance money. This sets a high bar for unions trying to protect their members' health benefits from allegedly fraudulent pharmaceutical marketing.

This summary was generated to explain the ruling in plain English and is not legal advice.

Browse Related

Facing something similar at work?

Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.

This ruling information is sourced from public court records via CourtListener.com. Case outcomes, claim types, and summaries are extracted using AI analysis and may be incomplete or inaccurate. It is provided for informational and educational purposes only and does not constitute legal advice.

See something wrong, or named in this ruling and want it corrected or redacted? Request a correction.